Search research articles
Contact Us
Filters
Showing results (521-530 of 540) with videos related to
Page
of 54
Sort By:
Hepatology (Baltimore, Md.)
|
April 8, 2015
Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis
K Rajender Reddy, Marc Bourlière, Mark Sulkowski, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 5, 2017
Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitors
Xiao Ding, Xuedong Dai, Kai Long, et al.
Journal of Medicinal Chemistry
|
November 9, 2024
Discovery of a Novel Macrocyclic Noncovalent CDK7 Inhibitor for Cancer Therapy
Hongfu Lu, Yihong Zhang, Jinxin Liu, et al.
Chemical Science
|
February 16, 2023
AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor
Feng Ren, Xiao Ding, Min Zheng, et al.
Journal of Medicinal Chemistry
|
August 14, 2020
Discovery of Pyrido[2,3-<i>b</i>]indole Derivatives with Gram-Negative Activity Targeting Both DNA Gyrase and Topoisomerase IV
Yimin Hu, Houguang Shi, Mingwei Zhou, et al.
The New England Journal of Medicine
|
April 15, 2014
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection
Nezam Afdhal, Stefan Zeuzem, Paul Kwo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 30, 2023
Construction of Host Plant Insect-Resistance Mutant Library by High-Throughput CRISPR/Cas9 System and Identification of A Broad-Spectrum Insect Resistance Gene
Lin Sun, Muna Alariqi, Yaxin Wang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
April 3, 2004
[First-line Xeloda (Capecitabine) treatment for advanced and recurrent colorectal cancer]
Zhong-zhen Guan, Dong-geng Liu, Bao-ming Yu, et al.
Nature Biotechnology
|
January 22, 2025
Quantum-computing-enhanced algorithm unveils potential KRAS inhibitors
Mohammad Ghazi Vakili, Christoph Gorgulla, Jamie Snider, et al.
Cell Reports. Medicine
|
August 17, 2022
Antibody therapy reverses biological signatures of COVID-19 progression
M Cyrus Maher, Leah B Soriaga, Anil Gupta, et al.
Page
of 54
Search research articles
Search
Showing results (521-530 of 540) with videos related to
Sort By:
Page
of 54
Hepatology (Baltimore, Md.)
|
April 8, 2015
Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis
K Rajender Reddy, Marc Bourlière, Mark Sulkowski, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 5, 2017
Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitors
Xiao Ding, Xuedong Dai, Kai Long, et al.
Journal of Medicinal Chemistry
|
November 9, 2024
Discovery of a Novel Macrocyclic Noncovalent CDK7 Inhibitor for Cancer Therapy
Hongfu Lu, Yihong Zhang, Jinxin Liu, et al.
Chemical Science
|
February 16, 2023
AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor
Feng Ren, Xiao Ding, Min Zheng, et al.
Journal of Medicinal Chemistry
|
August 14, 2020
Discovery of Pyrido[2,3-<i>b</i>]indole Derivatives with Gram-Negative Activity Targeting Both DNA Gyrase and Topoisomerase IV
Yimin Hu, Houguang Shi, Mingwei Zhou, et al.
The New England Journal of Medicine
|
April 15, 2014
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection
Nezam Afdhal, Stefan Zeuzem, Paul Kwo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 30, 2023
Construction of Host Plant Insect-Resistance Mutant Library by High-Throughput CRISPR/Cas9 System and Identification of A Broad-Spectrum Insect Resistance Gene
Lin Sun, Muna Alariqi, Yaxin Wang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
April 3, 2004
[First-line Xeloda (Capecitabine) treatment for advanced and recurrent colorectal cancer]
Zhong-zhen Guan, Dong-geng Liu, Bao-ming Yu, et al.
Nature Biotechnology
|
January 22, 2025
Quantum-computing-enhanced algorithm unveils potential KRAS inhibitors
Mohammad Ghazi Vakili, Christoph Gorgulla, Jamie Snider, et al.
Cell Reports. Medicine
|
August 17, 2022
Antibody therapy reverses biological signatures of COVID-19 progression
M Cyrus Maher, Leah B Soriaga, Anil Gupta, et al.
Page
of 54